Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Genetic Tech Spn ADR (GENE)

Genetic Tech Spn ADR (GENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Gene achieves key milestones and growth

MELBOURNE, Australia, July 28, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Completion of AffinityDNA Acquisition expanding global direct-to-consumer business

MELBOURNE, Australia, July 14, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
GeneType Risk Assessment Test onboarding in 16 clinics

MELBOURNE, Australia, July 01, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Acquisition of global direct to consumer ecommerce business

MELBOURNE, Australia, May 16, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies drives leadership in precision medicine with Multi-Risk Test

MELBOURNE, Australia, April 08, 2022 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ: GENE, ASX: GTG) (“GENE” or the “Company”), a global leader...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies Reports Q2 FY22 Cash Flow Results

Q2 momentum sets the stage for a strong FY22...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
GENE Presents Study Involving 200,000 Participants at 2021 San Antonio Breast Cancer Symposium

MELBOURNE, Australia, Dec. 10, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)
Genetic Technologies Announces New Partnership and geneType COVID-19 Risk Test Patent Allowance from the USPTO

MELBOURNE, Australia, Dec. 09, 2021 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GENE”), a global leader in...

GTG.AX : 0.039 (+2.63%)
GENE : 0.7650 (-1.92%)

Barchart Exclusives

Legendary Investor Muddy Waters Is Making a Rare Bullish Bet on This Gold Stock. Should You Buy It Too?
Carson Block from Muddy Waters just took a bullish position on Snowline Gold. Should you follow his example? Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar